Agreement to Amend Series C Convertible Preferred Stock Sample Contracts

AGREEMENT TO AMEND SERIES C CONVERTIBLE PREFERRED STOCK

Agreement to Amend Series C Convertible Preferred Stock • July 9th, 2024 • ReShape Lifesciences Inc. • Surgical & medical instruments & apparatus • Delaware

• Contract Type
  Agreement to Amend Series C Convertible Preferred Stock
• Filed
  July 9th, 2024
• Company
  ReShape Lifesciences Inc.
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  Delaware

THIS AGREEMENT TO AMEND SERIES C CONVERTIBLE PREFERRED STOCK (this “Agreement”), dated as of July 8, 2024, is by and among ReShape Lifesciences Inc., a Delaware corporation (formerly known as Obalon Therapeutics, Inc.) (the “Company”), and the undersigned holders of Series C Convertible Preferred Stock of the Company (collectively, the “Parties”).